Published in Cancer Res on December 14, 2012
Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet (2013) 5.48
MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov (2013) 3.33
The rise of regulatory RNA. Nat Rev Genet (2014) 3.02
Long noncoding RNAs and the genetics of cancer. Br J Cancer (2013) 2.98
Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet (2013) 2.59
Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget (2014) 2.31
Dynamic integration of splicing within gene regulatory pathways. Cell (2013) 2.25
Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget (2014) 1.90
Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res (2014) 1.83
Lung development: orchestrating the generation and regeneration of a complex organ. Development (2014) 1.66
Long Noncoding RNAs in Cancer Pathways. Cancer Cell (2016) 1.63
High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol (2014) 1.62
Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer (2013) 1.62
Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer (2014) 1.59
Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer (2014) 1.56
MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther (2014) 1.55
Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer (2015) 1.51
CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science (2016) 1.51
DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genomics (2015) 1.45
Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem (2014) 1.44
Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer (2017) 1.43
Long non-coding RNAs: modulators of nuclear structure and function. Curr Opin Cell Biol (2013) 1.43
A pathophysiological view of the long non-coding RNA world. Oncotarget (2014) 1.36
Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res (2015) 1.36
EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis (2014) 1.34
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol Cell Ther (2015) 1.32
MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta (2014) 1.30
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev (2015) 1.27
The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget (2015) 1.27
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines. Nucleic Acids Res (2014) 1.26
Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome Biol (2014) 1.25
Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol (2014) 1.23
Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene (2015) 1.22
Long noncoding RNAs: an emerging link between gene regulation and nuclear organization. Trends Cell Biol (2014) 1.19
microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep (2013) 1.18
Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nat Struct Mol Biol (2014) 1.18
Long noncoding RNAs: a potential novel class of cancer biomarkers. Front Genet (2015) 1.17
Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol (2014) 1.16
Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol (2013) 1.16
Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene (2015) 1.14
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget (2015) 1.12
Physiological roles of long noncoding RNAs: insight from knockout mice. Trends Cell Biol (2014) 1.12
Long noncoding RNAs: Re-writing dogmas of RNA processing and stability. Biochim Biophys Acta (2015) 1.08
Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer. Oncotarget (2016) 1.08
Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription (2014) 1.07
Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage. Dig Dis Sci (2013) 1.07
Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci (2013) 1.07
An emerging understanding of long noncoding RNAs in kidney cancer. J Cancer Res Clin Oncol (2014) 1.07
Long noncoding RNAs in cancer: from function to translation. Trends Cancer (2015) 1.06
The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget (2014) 1.06
MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer (2014) 1.06
Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57. Cell Death Dis (2016) 1.06
Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma. J Transl Med (2014) 1.04
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes (2013) 1.04
Integrating the roles of long and small non-coding RNA in brain function and disease. Mol Psychiatry (2014) 1.04
Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci (2016) 1.04
Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA. Sci Rep (2015) 1.04
BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition. Oncol Lett (2014) 1.04
FMLNCSIM: fuzzy measure-based lncRNA functional similarity calculation model. Oncotarget (2016) 1.04
Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci (2013) 1.03
Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Sci Rep (2015) 1.03
Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics (2013) 1.02
Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol (2015) 1.01
Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol (2014) 1.00
Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development. Brain Tumor Res Treat (2014) 0.99
LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis. Int J Clin Exp Med (2015) 0.99
Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Int J Clin Exp Pathol (2015) 0.98
From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev (2014) 0.98
ILNCSIM: improved lncRNA functional similarity calculation model. Oncotarget (2016) 0.96
Novel therapeutic targets for pancreatic cancer. World J Gastroenterol (2014) 0.96
An emerging role for long non-coding RNAs in cancer metastasis. Front Genet (2014) 0.95
A long noncoding RNA perturbs the circadian rhythm of hepatoma cells to facilitate hepatocarcinogenesis. Neoplasia (2015) 0.95
Epigenetics of lung cancer. Transl Res (2014) 0.95
Non-coding RNA: a new frontier in regulatory biology. Natl Sci Rev (2014) 0.95
Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol (2015) 0.94
Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med (2013) 0.93
Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer. Oncotarget (2016) 0.92
Long Noncoding RNAs: A New Regulatory Code in Metabolic Control. Trends Biochem Sci (2015) 0.92
The Clinical Relevance of Long Non-Coding RNAs in Cancer. Cancers (Basel) (2015) 0.92
Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett (2015) 0.92
Long non-coding RNAs in cancer and development: where do we go from here? Int J Mol Sci (2015) 0.92
The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol Med (2016) 0.91
Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma. Mol Genet Genomics (2014) 0.91
Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis. Dis Markers (2015) 0.90
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. J Clin Invest (2016) 0.89
The non-coding transcriptome as a dynamic regulator of cancer metastasis. Cancer Metastasis Rev (2014) 0.89
The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression. Oncotarget (2016) 0.89
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Res (2015) 0.89
The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer. J Transl Med (2015) 0.89
Epigenetic and transcriptional determinants of the human breast. Nat Commun (2015) 0.89
Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Sci Rep (2015) 0.89
Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets. Biomed Res Int (2015) 0.88
Long noncoding RNAs in biology and hematopoiesis. Blood (2013) 0.88
MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation. Int J Clin Exp Pathol (2015) 0.88
Long Non-Coding RNA NEAT1 Associates with SRp40 to Temporally Regulate PPARγ2 Splicing during Adipogenesis in 3T3-L1 Cells. Genes (Basel) (2014) 0.87
Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol Ther (2016) 0.87
Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor. J Cancer Res Clin Oncol (2015) 0.87
Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data. Database (Oxford) (2015) 0.87
Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer. Front Genet (2014) 0.87
Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis. Cell Death Dis (2016) 0.87
The hallmarks of cancer. Cell (2000) 113.05
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science (2007) 18.59
Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature (2011) 11.59
Breast cancer metastasis: markers and models. Nat Rev Cancer (2005) 9.93
The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell (2010) 8.66
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol (2011) 6.54
A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics (2007) 6.28
Metastasis: a question of life or death. Nat Rev Cancer (2006) 6.26
The SR protein family of splicing factors: master regulators of gene expression. Biochem J (2009) 5.98
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol (2012) 5.60
Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature (2007) 5.57
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell (2007) 5.40
The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev (2006) 4.94
Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology (2006) 4.70
3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell (2008) 4.54
ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell (2011) 4.26
A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev (2008) 3.85
Nuclear speckles. Cold Spring Harb Perspect Biol (2011) 3.04
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol (2011) 2.79
MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett (2010) 2.67
MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol (2011) 2.59
The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep (2012) 2.45
Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) (2010) 1.95
Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol (2011) 1.92
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol (2012) 1.90
Malat1 is not an essential component of nuclear speckles in mice. RNA (2012) 1.90
Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol (2009) 1.85
Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis (2008) 1.64
CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol (2007) 1.64
Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res (2011) 1.59
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Cancer Gene Ther (2004) 1.32
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut (2007) 1.17
Metastasis associated lung adenocarcinoma transcript 1 is up-regulated in placenta previa increta/percreta and strongly associated with trophoblast-like cell invasion in vitro. Mol Hum Reprod (2009) 1.15
High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Mol Cancer Res (2010) 1.11
NFAT promotes carcinoma invasive migration through glypican-6. Biochem J (2011) 1.09
Slit2/Robo1 signaling in glioma migration and invasion. Neurosci Bull (2010) 1.02
Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK). J Neurooncol (2008) 0.91
Latrophilin-2 is a novel component of the epithelial-mesenchymal transition within the atrioventricular canal of the embryonic chicken heart. Dev Dyn (2006) 0.88
Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54
Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol (2009) 11.50
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell (2003) 11.40
Long noncoding RNAs: functional surprises from the RNA world. Genes Dev (2009) 9.14
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90
From silencing to gene expression: real-time analysis in single cells. Cell (2004) 7.73
Nuclear speckles: a model for nuclear organelles. Nat Rev Mol Cell Biol (2003) 6.98
The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol (2012) 5.60
Regulating gene expression through RNA nuclear retention. Cell (2005) 5.58
Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med (2004) 5.21
53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature (2008) 5.11
MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res (2008) 5.06
Dynamics of single mRNPs in nuclei of living cells. Science (2004) 4.58
3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell (2008) 4.54
Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron (2012) 4.48
Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. Genes Dev (2007) 4.34
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature (2011) 4.04
Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat Genet (2001) 3.63
A genetic locus targeted to the nuclear periphery in living cells maintains its transcriptional competence. J Cell Biol (2008) 3.39
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet (2002) 3.25
A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J (2010) 3.18
The CD95 receptor: apoptosis revisited. Cell (2007) 3.13
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev (2010) 3.02
Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest (2006) 3.00
Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J (2004) 2.87
Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nat Cell Biol (2011) 2.85
Spatial and temporal regulation of Condensins I and II in mitotic chromosome assembly in human cells. Mol Biol Cell (2004) 2.78
Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature (2012) 2.63
Direct visualization of the co-transcriptional assembly of a nuclear body by noncoding RNAs. Nat Cell Biol (2010) 2.61
Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res (2014) 2.60
Biogenesis and function of nuclear bodies. Trends Genet (2011) 2.60
Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med (2011) 2.56
MALAT1 -- a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) (2013) 2.53
Identification of nuclear dicing bodies containing proteins for microRNA biogenesis in living Arabidopsis plants. Curr Biol (2007) 2.49
The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep (2012) 2.45
Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage. Mol Cell (2010) 2.39
The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta (2004) 2.30
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology (2014) 2.27
Nuclear neighborhoods and gene expression. Curr Opin Genet Dev (2009) 2.21
Sequential entry of components of the gene expression machinery into daughter nuclei. Mol Biol Cell (2003) 2.15
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood (2010) 2.14
Proteomic analysis of interchromatin granule clusters. Mol Biol Cell (2004) 2.12
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature (2010) 2.10
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev (2013) 2.07
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res (2006) 1.98
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol (2004) 1.96
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol (2012) 1.90
Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest (2011) 1.88
Differential regulation of strand-specific transcripts from Arabidopsis centromeric satellite repeats. PLoS Genet (2005) 1.83
Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res (2010) 1.82
Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin. Mol Ther (2011) 1.82
Chromatin dynamics and gene positioning. Cell (2008) 1.81
A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat Genet (2006) 1.79
Argonaute proteins regulate microRNA stability: Increased microRNA abundance by Argonaute proteins is due to microRNA stabilization. RNA Biol (2011) 1.78
Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood (2010) 1.77
Chromatin dynamics. Annu Rev Biophys (2010) 1.70
Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition. Bioorg Med Chem Lett (2011) 1.60
Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat Cell Biol (2002) 1.60
HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J (2003) 1.59
Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res (2011) 1.59
Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis. Cancer Biol Ther (2002) 1.58
Transient receptor potential canonical type 3 channels facilitate endothelium-derived hyperpolarization-mediated resistance artery vasodilator activity. Cardiovasc Res (2012) 1.56
Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells. Arch Pharm Res (2010) 1.55
Induction of dendritic cell maturation by β-glucan isolated from Sparassis crispa. Int Immunopharmacol (2010) 1.53
Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology (2008) 1.52
An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem (2002) 1.48
Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett (2004) 1.48
Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res (2006) 1.46
The cyclin A1-CDK2 complex regulates DNA double-strand break repair. Mol Cell Biol (2004) 1.43
MicroRNA biogenesis and cancer. Methods Mol Biol (2011) 1.39
PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev (2006) 1.36
Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci U S A (2006) 1.35
Disassembly of interchromatin granule clusters alters the coordination of transcription and pre-mRNA splicing. J Cell Biol (2002) 1.34
Hypophosphorylated SR splicing factors transiently localize around active nucleolar organizing regions in telophase daughter nuclei. J Cell Biol (2004) 1.32
Structural requirement(s) of N-phenylthioureas and benzaldehyde thiosemicarbazones as inhibitors of melanogenesis in melanoma B 16 cells. Bioorg Med Chem Lett (2010) 1.32
The life of an mRNA in space and time. J Cell Sci (2010) 1.31
Chromatin organization and transcriptional regulation. Curr Opin Genet Dev (2012) 1.31
Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates. Arterioscler Thromb Vasc Biol (2013) 1.30
JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm (Lond) (2008) 1.30
Complexome profiling identifies TMEM126B as a component of the mitochondrial complex I assembly complex. Cell Metab (2012) 1.29
Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology (2013) 1.26
Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling. Hepatology (2010) 1.23
miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J Invest Dermatol (2012) 1.23
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood (2011) 1.22
Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res (2005) 1.22
Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res (2011) 1.21
Centromere positioning and dynamics in living Arabidopsis plants. Mol Biol Cell (2005) 1.21
Rapid, diffusional shuttling of poly(A) RNA between nuclear speckles and the nucleoplasm. Mol Biol Cell (2005) 1.21
Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J Biol Chem (2002) 1.21
Identification of novel PPARgamma target genes in primary human adipocytes. Gene (2005) 1.20
Lamin A/C is expressed in pluripotent mouse embryonic stem cells. Nucleus (2013) 1.18
Tissue-specific expression and dynamic organization of SR splicing factors in Arabidopsis. Mol Biol Cell (2004) 1.18
Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int J Oncol (2003) 1.18